510(k) K180835
K180835 is an FDA 510(k) premarket notification submitted by Sekisui Diagnostics P.E.I., Inc. for the device "SEKURE Acetaminophen L3K Assay". The FDA issued a decision of Substantially Equivalent on Feb 8, 2019. The device falls under product code LDP (Colorimetry, Acetaminophen), a Class II device regulated under 21 CFR 862.3030. Sekisui Diagnostics P.E.I., Inc. has 5 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 8, 2019
- Date Received
- Mar 30, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Colorimetry, Acetaminophen
- Device Class
- Class II
- Regulation Number
- 862.3030
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Sekisui Diagnostics P.E.I., Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.